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Abstract
 
The 
 
 
 
-herpesviruses are oncogenic B cell lymphotrophic viruses that establish life-long latency
in the host. Murine 
 
 
 
-herpesvirus 68 (MHV-68) infection of mice represents a unique system
for analyzing 
 
 
 
-herpesvirus latency in splenic B cells at different stages of infection. After intra-
nasal infection with MHV-68 we analyzed the establishment of latency 14 days after infection,
and the maintenance of latency 3 months after infection in different purified subpopulations of
B cells in the spleen. The data show that MHV-68 latency is mainly established in germinal
center B cells and that long-term latency is preferentially maintained in two different subsets of
isotype-switched B cells, germinal center and memory B cells. Cell cycle analysis indicates that
MHV-68 is located in both cycling and resting isotype-switched B cells. Analysis of viral gene
expression showed that both lytic and latent viral transcripts were differentially expressed in
germinal center and memory B cells during long-term latency. Together, these observations
suggested that 
 
 
 
-herpesviruses exploit the B cell life cycle in the spleen.
Key words: murine herpesvirus 68 • gammaherpesvirinae • viral latency • B lymphocytes • 
germinal centers
 
Introduction
 
The human 
 
 
 
-herpesviruses, EBV and Kaposi’s sarcoma-
associated herpesvirus (KSHV),
 
* 
 
are persistent oncogenic
viruses that are maintained in a quiescent state in immuno-
competent individuals. Immunosuppression, however, is
frequently associated with virus reactivation and the devel-
opment of malignancies. It is therefore important to under-
stand how these B lymphotrophic viruses establish and
maintain a persistent infection in the immunocompetent
host. Initial infection by EBV polyclonally activates B cells,
yet long-term latency is maintained in resting B cells. It has
been suggested that the virus exploits normal B cell biology
by gaining entry into the long-lived, quiescent memory B
cell compartment through germinal center reactions (1–4).
Due to the generally asymptomatic characteristics of the
initial infection in man, and the stringent species specificity
of the virus precluding the use of small animal models, the
establishment of EBV latency during the early stages of in-
fection cannot be directly assessed in vivo. Little is known
about the establishment and maintenance of KSHV latency.
Murine 
 
 
 
-herpesvirus 68 (MHV-68), a 
 
 
 
2-herpesvirus,
is structurally and biologically similar to the human 
 
 
 
-her-
pesviruses and provides an important experimental in vivo
model of 
 
 
 
-herpesvirus infection in the natural host (5–9).
Intranasal infection of mice with MHV-68 causes an acute
respiratory infection that is rapidly resolved, followed by
the establishment of splenic latency, which peaks 14 d after
infection (10). Analogous to the human 
 
 
 
-herpesviruses, B
cells are polyclonally activated and a major reservoir of la-
tent MHV-68 (11–14). B cell activation and the develop-
ment and maintenance of germinal center and memory B cells
can readily be studied in the murine spleen.
In these studies, we have phenotypically characterized
viral reservoirs in splenic B cells during the establishment
and maintenance phases of latency, 14 d and 3 mo after in-
tranasal infection. The data show that viral latency is estab-
lished at extremely high frequencies in germinal center B
cells and is maintained long-term in two subsets of class-
switched B cells, memory and germinal center B cells.
Analysis of viral gene transcription shows the expression of
multiple viral transcripts in memory and germinal center B
cells during latent infection, consistent with a complex in-
teraction between the virus and the host. Our data ana-
lyzing long-term MHV-68 latency in the murine spleen
suggest that the overall strategy for maintaining latency
by taking advantage of the normal B cell biology and
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gaining entry into the memory B cell pool is shared by
the 
 
 
 
-herpesviruses.
 
Materials and Methods
 
Virus and Mice.
 
MHV-68, clone WUMS (15), was propa-
gated and titered on monolayers of NIH-3T3 fibroblasts
(CRL1568; American Type Culture Collection). C57BL/6J (B6)
mice were purchased from Taconic Farms and housed in BL3
containment. The Institutional Animal Care and Use Committee
at the Trudeau Institute approved all studies described here. Mice
were anesthetized with 2,2,2 tribromoethanol and inoculated in-
tranasally with 400 PFU of MHV-68 in 30 
 
 
 
l PBS.
 
Cell Staining and Purification.
 
Isolation of spleen cell popula-
tions was done using a FACSVantage™ SE/Diva sorter (Becton
Dickinson) and antibodies were obtained from BD Biosciences.
Pooled splenocytes from five to seven mice were used in all ex-
periments. To isolate B cells, spleen cells were incubated with Fc-
block (2.4G2) and then stained with CD11c (HL3), CD11b
(M1/70), CD3 (17A2), and B220 (RA3–6B2). B cells were
sorted as B220
 
  
 
and negative for the other markers. To isolate ac-
tivated and resting B cells 14 d after infection, T cells were mag-
netically depleted with beads (Dynal) after incubation with anti–
Thy-1.2 supernatant (AT83). Remaining cells were incubated
with Fc-block and stained with peanut agglutinin (PNA; Sigma-
Aldrich), CD11b, CD11c, CD3, and B220. Activated B cells
were sorted as B220
 
  
 
PNA
 
high 
 
and resting B cells as B220
 
 
 
PNA
 
low
 
, and negative for all other markers (14). To isolate naive
germinal center and memory B cells 3 mo after infection, spleen
cells were incubated with Fc-block and stained with IgD (11-
26c.2a), IgM (R6-60.2), CD38 (90), CD5 (53-7.3), and a cock-
tail of antibodies to detect isotype switching (IgA [C10-1], IgG
 
1
 
[A85-1], IgG
 
2ab 
 
[R2-40], and IgG
 
3 
 
[R40-82]). CD5
 
  
 
cells were
gated out to avoid T and B-1 cell contamination. Naive B cells
were sorted as non-isotype-switched IgD/M
 
 
 
, germinal center B
cells as isotype-switched IgD/M
 
 
 
CD38
 
low
 
, and memory B cells
as isotype-switched IgD/M
 
 
 
CD38
 
high
 
. Anti-Fas (Jo2) was used to
characterize germinal center B cells.
Cell cycle analysis was performed on isotype-switched B cells
(CD19
 
  
 
IgA
 
  
 
IgG
 
1
 
  
 
IgG
 
2ab
 
  
 
IgG
 
3
 
  
 
IgD/M
 
 
 
) 3 mo after infec-
tion. After surface staining, cells were permeabilized with 0.05%
saponin and DNA was stained by adding 10 
 
 
 
g/ml Hoechst
33342 (Sigma-Aldrich) to the buffer 30 min before the sorting.
Cells were sorted after the exclusion of doublets and the postsort-
ing purity of the G
 
0
 
 
 
G
 
1 
 
population was 99%. The cell cycle anal-
ysis was performed using FloJo
 
® 
 
(Tree Star, Inc.) and according to
the mathematical model of Watson et al. (16) without applying
any parameter constraints.
 
Limiting Dilution-nested PCR.
 
The frequency of cells contain-
ing the MHV-68 genome was determined by a combination of
limiting dilution analysis (LDA) and nested PCR (17, 18). Sorted
cells were serially diluted in uninfected NIH-3T3 fibroblasts in
96-well plates, lysed, and DNA amplified by PCR as previously
described (19) using primers specific for MHV-68 ORF50. A
2-
 
 
 
l aliquot of the product was then reamplified using nested
primers and the final product was analyzed by ethidium bromide
staining of DNA after electrophoresis in a 3% agarose gel. This
procedure was able to consistently detect a single copy of the tar-
get sequence. 12 replicates were assessed for each cell dilution and
linear regression analysis was performed to determine the recipro-
cal frequency (95% degree of confidence) of cells positive for
MHV-68 DNA. As controls of nested PCR, 10
 
4 
 
NIH-3T3 cells
 
per well with and without plasmid DNA containing the MHV-
68 ORF 50 gene were included in each 96-well plate. At least
three independent experiments were used to determine the mean
reciprocal frequency and standard deviation of MHV-68 DNA
 
 
 
cells in each sorted cell population.
 
Virus LDA.
 
LDA of infectious virus titer was performed as
previously described (14) with minor modifications. In brief, the
presence of lytic virus was determined by analysis of the total cell
lysate of the FACS
 
®
 
-purified spleen populations after a single cy-
cle of freeze/thawing. Serial dilutions of the cell equivalents were
plated onto murine embryonic fibroblast monolayers (1.5 
 
  
 
10
 
4
 
/
well) in flat-bottom 96-well plates. 24 wells were plated for each
dilution and the number of wells exhibiting cytopathic effect
(CPE) was counted after 3 wk of culture. Control experiments
have shown that the limit of detection of the infectious virus-
LDA assay is 1 PFU in 10
 
6 
 
cells. One cycle of freeze/thawing has
a 
 
 
 
20% reduction in lytic virus titers (20). Therefore, our limit of
detection is 1.2 PFU in 10
 
6 
 
cells.
 
Gene Expression Analysis.
 
The gene expression analysis was
adapted from human and murine 
 
 
 
-herpesvirus gene expression
studies (19, 21). Purified cell populations were aliquoted in 10
 
5
 
cells/aliquot and total RNA free of DNA was isolated by extrac-
tion with RNAqueous-4PCR (Ambion) according to the manu-
facturer’s guidelines. cDNA was synthesized from total RNA
using M-MLV RT (GIBCO BRL) and random hexamers
(Roche). For each experiment, we combined cDNA from three
independent cell purifications, each one containing seven mice,
to increase the likelihood of detecting transcripts that may be
sporadically expressed. This allowed RT-PCR to be performed
for all genes from one cDNA pool. 10-
 
 
 
l aliquots of cDNA,
each one containing cDNA from 
 
 
 
12 latently infected cells,
were then amplified by PCR in a 25-
 
 
 
l reaction containing
primers (6.25 
 
 
 
mol each) specific for MHV-68 open reading
frames (ORFs) M1, M2, M3, M9, M11, 50, 72, 73, 74, and K3
(19), 1 U TaKaRa Ex Taq (Takara Biomedicals), 2.5 
 
 
 
l 10
 
  
 
Ex
Taq buffer (Takara Biomedicals), and 3 
 
 
 
l dNTP mixture
(Takara Biomedicals). Amplification was for 45 cycles (94
 
 
 
C for
60 s; 67
 
 
 
C for 60 s; and 72
 
 
 
C for 30 s) followed by a 7-min ex-
tension at 72
 
 
 
C. A 2-
 
 
 
l aliquot was then reamplified using a set
of gene-specific nested primers (19) for 30 cycles. Negative con-
trol reactions for each sample lacked RT. Reactions were in-
cluded to amplify the mouse 
 
  
 
actin mRNA as a control for
RNA quality and they were performed for 30 cycles. Amplified
DNA was then analyzed by gel electrophoresis. The sensitivity of
our RT-PCR assay is such that we can detect M2 expression in a
single latently MHV-68–infected S11 B cell diluted in 10
 
5 
 
non-
infected 3T3 cells (unpublished data). The high frequencies of la-
tently infected cells in the purified populations of B cells (see Ta-
ble II) were well within the predicted sensitivity of the nested
RT-PCR assays for viral gene transcription. Each RT-PCR re-
action was run in duplicate for each experimental sample and the
experiment was done twice accounting for a total of 42 spleens
analyzed from 6 FACS
 
® 
 
sortings.
 
Results
 
Latency Is Established Preferentially in Splenic Germinal Cen-
ter B Cells.
 
Previous determination of the frequency of la-
tently infected subsets of spleen cells was performed at the
peak of latency using an in vitro reactivation assay that de-
pends on the ability of latently infected cells to react and
form viral plaques on a susceptible cell monolayer (14). 
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MHV-68 latency peaks 14 d after infection in the spleen
and rapidly falls to levels at the limit of detection (10), pre-
cluding frequency analysis of long-term latency. Recently a
more sensitive assay has been developed, which is based on
the frequency of cells harboring viral genome determined
by PCR analysis of cells plated in limiting dilution (LDA-
PCR; reference 17). Although both lytically and latently
infected cells harbor viral genome, in the absence of pre-
formed infectious virus the presence of viral DNA indicates
latent virus (17, 18). In this study, we took advantage of
this sensitive assay to quantitatively monitor long-term la-
tency in different cell subsets in the spleen. Spleens were
magnetically depleted of T cells 14 d after infection.
Splenic B cells (B220
 
  
 
CD11c
 
  
 
CD11b
 
  
 
CD3
 
 
 
) were sep-
arated by FACS
 
® 
 
sorting into highly purified phenotypic
subsets representing activated/germinal center cells (B220
 
 
 
PNA
 
high
 
) and resting B cells (B220
 
  
 
PNA
 
low
 
; Fig. 1, A–C).
Initially, the frequency of latency in the purified B cell
populations harboring viral genome and preformed infec-
tious virus was analyzed at day 14, the peak of viral latency.
The data were plotted as percentage of wells positive for
PCR or CPE (Fig. 2) and linear regression analysis was
used to determine the frequency of cells containing viral
DNA (Table I). The results showed an absence of infec-
tious lytic MHV-68 in both resting and germinal center B
cells, eliminating the possibility that genome-positive cells
reflected infectious virus (Fig. 2). The data (Table I) show
that an extremely high frequency (1 in 8) of germinal cen-
ter B cells harbored latent virus at the peak of latency (14 d
after infection), compared with a frequency of 1 in 2,700
for resting B cells. Although the purity of the resting B cells
was 
 
 
 
98%, the high frequency of latency among the 0.03%
of contaminating germinal center B cells accounted for
 
 
 
10% of the latently infected resting B cells. The observa-
tion that latency is preferentially in the activated/germinal
center B cells is consistent with our previous analysis using
the reactivation-based assay (14), but the frequency ob-
tained is 100-fold higher. This quantitative difference may
reflect the relative inability of B cells, especially activated B
cells, to survive during the culture period required for virus
reactivation. For example, it has been shown that 40–50%
of germinal center B cells undergo apoptosis within 5 h of
culture (22). The difference in frequency may also reflect
qualitative differences in latently infected B cells, as sug-
gested by our previous observation that not all cells latently
infected with MHV-68 can be reactivated in culture (18).
 
MHV-68 Maintains Long-Term Latency in Isotype-switched
B Cells.
 
Next, we measured the frequency of latency in
splenic B cells during long-term infection. Analysis of pu-
rified splenic B cells 3 mo after infection (Fig. 3) using
LDA-PCR showed that viral DNA was detectable, and in-
fectious virus-LDA showed that B cells lacked infectious
virus (Fig. 4 A). The data in Table II show that latency
among total B cells was significantly diminished relative to
the peak of latency but was maintained at readily detect-
able frequencies (1 in 27,000). In addition, the absolute
numbers of latently infected B cells dropped dramatically
from 
 
 
 
3 
 
  
 
10
 
6
 
/spleen at the peak of latency to 
 
 
 
10
 
3
 
/
spleen 3 mo after infection (Table II). The finding that
MHV-68 latency is maintained at a relatively low fre-
quency in splenic B cells during long-term infection raised
the possibility that latency might be preferentially associ-
ated with distinct phenotypic populations of B cells.
Therefore, we analyzed latency among different subsets of
splenic B cells 3 mo after infection. Using FACS
 
® 
 
sorting,
splenic B cells were purified as naive (IgD/M
 
 
 
) and iso-
type-switched (IgA
 
  
 
IgG
 
1
 
  
 
IgG
 
2ab
 
  
 
IgG
 
3
 
 
 
) B cells as shown
in Fig. 3, A–C. At this time point, activated/germinal cen-
ter B cells could not be sorted on the basis of PNA binding
because of their low frequency and low level of PNA
Figure 1. Flow cytometry analysis of
MHV-68–infected mice spleen B cells
14 d after infection. (A) Germinal cen-
ter and resting B cells were purified.
CD3 , CD11b , and CD11c   cells
were gated out and resting B cells were
then sorted as B220  PNAlow and ger-
minal center B cells as B220  PNAhigh.
(B) Resting B cells (B220  PNAlow) iso-
lated 14 d after infection were recov-
ered with a mean purity of 98.15% and
the contaminating fraction was 1.5%
non-B220   cells and 0.03% B220 
PNAhigh cells. (C) Germinal center B
cells (B220  PNAhigh) isolated 14 d after
infection were recovered with a mean
purity of 98.64% and the contaminating
fraction was 0.47% non-B220  cells and
0.83% B220  PNAlow cells.
Figure 2. MHV-68 establishes latency in the spleen mainly in germinal
center B cells. Spleen B cells 14 d after infection were sorted as (A) germi-
nal center B cells and (B) resting B cells. The purified cells were analyzed
by two different methods to determine the frequency of cells carrying
MHV-68. The frequency of genome-positive cells was determined by
LDA-PCR assay ( ). The frequency of infectious virus was determined
by infectious virus-LDA ( ). The percentages of CPE or PCR reactions
that scored positive as a function of the number of cells analyzed are
shown. Data represent the average of three to four experiments and the
error bars represent SD. 
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binding. Therefore, we took advantage of the observation
that CD38 can be used to distinguish memory and germi-
nal center class-switched B cells (23–25), and further sepa-
rated isotype-switched B cells by sorting, based on CD38
expression, into memory B cells (CD38high) and germinal
center B cells (CD38low; Fig. 3, D and E). An additional
key difference in the phenotype of germinal center and
memory B cells is the expression level of two activation
markers, PNA and Fas (23). We corroborated the identity
of the subsets of cells as germinal center and memory B
cells by showing that isotype-switched CD38low germinal
center B cells and isotype-switched CD38high memory B
Table I. MHV-68 Latency within Splenic B Cells During the Establishment of Latency (14 d after Infection) Is Mainly Established in 
Germinal Center B Cells
Cells
Reciprocal frequency of
genome-positive cells (SD)a Percent of total spleenb Total number of cellsc Latently infected cellsd
Resting B cellse 2,700 (1,600) 45  9   107 3.3   104f
Germinal center B cellsg 8 (5) 10.8 2.2   107 2.7   106
Data shown are the mean of three to four independent experiments, each analyzing pooled spleens from five to seven mice. Standard deviation values
are shown between brackets.
aFrequencies   95% confidence limits were determined by linear regression analysis of LDA-PCR data.
bPercentage of each subset of total spleen cells was determined by FACS® analysis.
cTotal number of cell subset per spleen based on an estimate of 2   108 total cells/spleen 14 d after infection.
dNumber of latently infected cells based on the frequency of viral genome-positive cells within each cell type and its estimated total number per spleen.
eResting B cells were sorted as B220  PNAlow with 98.15% purity. The contaminating fraction was 1.5% non-B cells and 0.03% germinal center B cells.
fThe 0.03% contamination with germinal center B cells, due to their high level of infection (one in eight), could account for one genome positive
cell in every 3,413 purified resting B cells. Therefore, they could contribute as many as 3.2   103 cells to the total number (3.3   104) of latently in-
fected resting B cells.
gGerminal center B cells were sorted as B220  PNAhigh with 98.64% purity. The contaminating fraction was 0.47% non-B cells and 0.83% resting B cells.
Figure 3. Flow cytometry analysis of MHV-68–infected spleen cells 3
mo after infection. (A) Spleen B cells were purified as isotype-switched cells
(IgA , IgG1
 , IgG2ab
 , IgG3
 ) and naive cells (IgM/D ). (B) Naive B cells
(IgM/D ) were obtained with a mean purity of 99% and the contaminating
fraction was 0.8% non-B cells and 0.02% isotype-switched B cells. (C) Iso-
type-switched B cells (IgA , IgG1
 , IgG2ab
 , IgG3
 ) were further separated
into memory and germinal center subpopulations on the basis of CD38 ex-
pression. (D) Germinal center B cells (isotype-switched CD38low) were re-
covered with a mean purity of 96% and the contaminating fraction was
2.23% nonisotype-switched cells and 1.9% memory B cells. (E) Memory B
cells (isotype-switched CD38high) were recovered with a mean purity of
95% and the contaminating fraction was 2.23% nonisotype-switched cells
and 2.29% germinal center B cells. (F) PNA expression on germinal center
(isotype-switched CD38low, gray curve) and memory (isotype-switched
CD38high, empty curve) B cells 3 mo after infection. (G) Fas expression on
germinal center (isotype-switched CD38low, gray curve) and memory (iso-
type-switched CD38high, empty curve) B cells 3 mo after infection.
Figure 4. MHV-68 maintains latency in every subset of splenic B cells.
Spleen B cells 3 mo after infection were sorted as (A) total B cells, (B) na-
ive B cells, (C) memory B cells, and (D) germinal center B cells. The pu-
rified cells were analyzed by two different methods to determine the fre-
quency of cells carrying MHV-68. The frequency of genome-positive
cells was determined by LDA-PCR assay ( ). The frequency of infec-
tious virus was determined by infectious virus-LDA ( ). The percentages
of CPE or PCR reactions that scored positive as a function of the number
of cells analyzed are shown. Data represent the average of three to four
experiments and the error bars represent SD.1367 Flaño et al.
cells expressed high and low levels, respectively, of both
PNA and Fas (Fig. 3, F and G).
Analysis of highly purified phenotypic subsets of splenic
B cells by LDA-PCR and infectious virus-LDA showed
that viral genome was detectable at distinct levels in each
population and that infectious virus was not detectable in
any of the B cell subsets analyzed (Fig. 4, B–D). The ab-
sence of lytic virus in any of the populations analyzed is
consistent with the interpretation that cells harboring viral
DNA 3 mo after the initial infection are latently infected.
As shown in Table II, latency was maintained at compara-
ble frequencies in both memory and germinal center B cells
(1 in 3,100 and 1 in 1,100, respectively). Although these
combined populations represent a low percentage of spleen
cells ( 1.5%), they contain most of the latently infected
cells 3 mo after infection. Despite the low frequency of la-
tency in naive B cells (1 in 290,000), these cells also con-
tribute to the latency pool as they represent most of the B
cells in the spleen. The high purity of the sorted naive B
cells, with only 0.02% contamination by isotype-switched
B cells, suggested that the presence of viral genome in the
naive B cells could not be attributed solely to the presence
of contaminating isotype-switched B cells. It is not possible
to determine whether these latently infected cells are a small
percentage of truly naive B cells or are located exclusively in a
small subpopulation of IgD  IgM  memory B cells (26, 27).
MHV-68 Maintains Long-Term Latency in Cycling and
Resting Isotype-switched B Cells. As latency is harbored
both in memory and germinal center B cells in the spleen,
we predicted that both resting and cycling B cells harbored
viral DNA during long-term latent infection. To address
this possibility, we sorted isotype-switched splenic B cells
during long-term infection based on their DNA content
into G0 G1  and S G2/M, and performed LDA-PCR
analysis on the populations obtained. As shown in Fig. 5,
G0 G1 cells constituted 94.9% and S G2/M cells consti-
tuted 5.3% of the isotype-switched B cell population. Both
subsets of cells harbored virus and linear regression analysis
determined that the frequencies of viral content were simi-
lar (1 in 3,400 in G0 G1 cells and 1 in 3,300 in S G2/M
cells; Fig. 5). Taking into account the percentage of cells in
each phase of the cell cycle, their viral frequencies, and the
total number of isotype-switched cells per spleen (Table II),
Table II. MHV-68 Latency in the B Cell Compartment During Latent Infection (3 mo after Infection) Is Mainly Maintained in Memory and 
Germinal Center Cells
Cells
Reciprocal frequency of
genome-positive cells (SD)a Percent of total spleenb Total number of cellsc Latently infected cellsd
Total B cellse 27,000 (4,600) 42 2.5   107 913
Naive B cellsf 290,000 (150,000) 36 2.2   107 74g
Memory B cellsh 3,100 (2,400) 0.99 5.9   105 189
Germinal center B cellsi 1,100 (469) 0.44 2.6   105 233
Data shown are the mean of three to four independent experiments, each analyzing pooled spleens from five to seven mice. Standard deviation values 
are shown between brackets.
aFrequencies   95% confidence limits were determined by linear regression analysis of LDA-PCR data.
bPercentage of each subset of total spleen cells was determined by FACS® analysis.
cTotal number of cell subset per spleen based on an estimate of 6   107 cells/spleen.
dNumber of latently infected cells based on the frequency of viral genome-positive cells within each cell type and its estimated total number per
spleen.
eB cells were sorted as B220  with 99.17% purity. The contaminating fraction was 0.75% non-B cells.
fNaive B cells were sorted as IgD/M  with 99% purity. The contaminating fraction was 0.8% non-B cells and 0.02% isotype-switched cells.
gThe 0.02% contamination with isotype-switched B cells, due to their high level of infection (1 in 2,100), could account for 1 genome-positive cell
in every 5,004 purified resting B cells. Therefore, they would make a contribution of one to two cells to the total number (74) of latently infected
naive B cells.
hMemory B cells were sorted as isotype-switched (IgG1
 , IgG2ab
 , IgG3
 
, IgA ) CD38high with 95% purity. The contaminating fraction was 2.23%
nonisotype-switched B cells and 2.9% germinal center B cells.
iGerminal center B cells were sorted as isotype-switched (IgG1
 , IgG2ab
 , IgG3
 
, IgA ) CD38low with 96% purity. The contaminating fraction was
2.23% nonisotype-switched B cells and 1.9% memory B cells.
Figure 5. Detection of MHV-68–infected cells in purified G0 G1 and
S G2/M subpopulations of isotype-switched spleen B cells 3 mo after in-
fection. (A) FACS® analysis of the DNA content of isotype-switched B
cells gated as CD19  IgA  IgG1
  IgG2ab
  IgG3
  IgD/M  before the frac-
tionation into G0 G1 (94.9% of the population) and S G2/M (5.3% of
the population). The percentages are the average of two independent ex-
periments. (B) The percentage of isotype-switched cells into G0 G1 and
S G2/M harboring viral genome was assessed by LDA-PCR assay. The
analysis shown is representative of two independent experiments, each
one pooling seven spleens 3 mo after MHV-68 infection.1368 Establishment and Maintenance of  -Herpesvirus Latency
there were 240 latently infected cells in the G0 G1 popula-
tion and 14 in the S G2/M population. Thus, MHV-68 is
detected in cycling as well as resting isotype-switched B
cells in the spleen during long-term latency.
MHV-68 Gene Expression During Long-Term Latency.
An important step in understanding the virus–host interac-
tions involved in maintaining viral latency in an immuno-
competent host, is to identify patterns of viral gene expres-
sion. The multiple programs of EBV latency-associated
gene expression are thought to reflect exploitation by this
human  -herpesvirus of the host B cell biology, in that
patterns of latency gene expression reflect the differentia-
tion stage of the infected B cell (21). However, little is
known about MHV-68 gene expression in vivo during
long-term latency and the analysis has never been per-
formed focusing on B cells, the major viral reservoir in the
spleen. Nested RT-PCR analysis was used to detect RNA
encoded by regions of the MHV-68 genome that contain
candidate latency-associated or lytic genes, described in
Table III, using a previously characterized panel of primers
(19). Analysis of cDNA from a latently infected B cell tu-
mor line, S11 (28), confirmed that the sizes of the tran-
scripts detected were correct (Fig. 6 A). Therefore, we
analyzed viral transcripts from FACS®-purified germinal
center and memory B cells from the spleens of MHV-68–
infected mice 3 mo after infection. Unexpectedly, there
was expression of a wide variety of viral transcripts in both
resting memory and activated germinal center B cells. As
shown in Fig. 6 B, memory B cells contained transcripts
specific for 8 out of 10 ORFs tested, including M1, M2,
M9, ORF 50, ORF 72, ORF 73, ORF 74, and K3,
whereas germinal center B cells expressed a subset of these
transcripts, including M1, M2, M9, and ORF 72. Interest-
ingly, two genes associated with lytic virus, K3 and
ORF50, were expressed in memory but not germinal cen-
ter B cells and the expression of two genes thought to be
latency associated, M3 and M11, was never detected in any
of the samples analyzed. Bearing in mind that we are assess-
ing viral transcripts rather than bona fide gene expression,
and that we are not technically able to analyze transcripts
on a per cell basis, the data are consistent with the conclu-
sion that MHV-68 maintains transcript expression during
long-term latent infection and suggest key differences in
gene expression between different B cell subpopulations.
Discussion
This study represents the first detailed characterization of
splenic B cell subsets in which  -herpesvirus latency is es-
Table III. MHV-68 Lytic and Latency-associated Transcripts Analyzed
Gene Function and/or homology References
M1 Serpin homologue (poxvirus), M3 homologue, suppresses reactivation from latency 59
M2 Differentially required for acute replication and establishment of latency 60, 61
M3 Chemokine scavenger 40, 46, 47
M9 Unknown 15
M11 Bcl-2 homologue (EBV, KSHV), apoptosis inhibitor 48, 62
ORF 72 Cyclin-D homologue (KSHV), transforming potential, controls reactivation from latency 63–65
ORF 73 Putative genome maintenance function based on homology to KSHV-LANA 15
ORF 74 G protein–coupled receptor; homology to IL-8R (KSHV), transforming potential 66
ORF 50 Lytic cycle activator, homologous to EBV-Rta transactivator 42–44
K3 Homologous to KSHV K3 and K5, inhibits class I antigen presentation 67, 68
Figure 6. (A) Detection of MHV-68 gene expression in the tumor B
cell line S11. Total RNA from S11 cells was subjected to RT-PCR as
described in Materials and Methods. (B) Detection of MHV-68 gene ex-
pression in purified memory and germinal center B cells. Spleen cells
were sorted and subjected to RT-PCR and agarose gel electrophoresis as
described in Materials and Methods. Primers specific for MHV-68 ORFs
M1, M2, M3, M9, M11, 72, 73, 74, K3, and 50 and for mouse   actin
were used as indicated. Control reactions lacking RT are also shown.1369 Flaño et al.
tablished early after infection and maintained during long-
term latency. During the establishment of viral latency in
the spleen, MHV-68 is preferentially located in germinal
center B cells. The major long-term reservoir of latent vi-
rus is isotype-switched B cells, with memory and germinal
center B cells making equal contribution. Thus, splenic
germinal center B cells have a key role both in the estab-
lishment and maintenance of viral latency. In addition,
gene expression analysis shows that multiple viral transcripts
are expressed in memory and germinal center B cells iso-
lated ex vivo from long-term latently infected mice.
Remarkably, the data show that during the establishment
phase of viral latency, one in eight germinal center B cells
harbors MHV-68 virus. Although this finding might be in-
cidental for MHV-68 biology, we favor the interpretation
that this extremely high frequency suggests that MHV-68
exploits germinal center reactions during the establishment
of latency in the host B cell compartment. Two different
strategies are possible. First, the virus can directly activate
naive B cells to become latently infected germinal center
cells. Second, the virus can latently infect any B cell, with
infection of germinal center B cells being much more effi-
cient. In support of viral activation of naive B cells, our
previous phenotypic analysis of nongerminal center B cells
14 d after infection shows them to be phenotypically heter-
ogeneous, with a subset showing signs of early activation
markers (14). Regardless of whether naive infected B cells
progress through a germinal center reaction or whether
germinal center B cells are directly infected with a high ef-
ficiency, the data suggest that the virus takes advantage of
germinal center reactions to efficiently establish latency in
the spleen. This important role of germinal center B cells in
 -herpesvirus latency is consistent with our previous analy-
sis of CD28    mice, which are deficient in germinal center
reactions. The data showed that although B cell latency is
established in CD28    mice, the efficiency is reduced by
 10-fold (14). Despite this, latency is maintained at normal
levels for  90 d after infection (18) probably due to the
fact that CD28    mice produce activated B cells after
MHV-68 infection (14) and to their ability to generate iso-
type-switched memory B cells that have undergone affinity
maturation in the absence of germinal centers by alternative
mechanisms (29–31). Thus, although the virus may prefer-
entially utilize germinal center cells, they are not absolutely
required for the establishment of latency.
The observation that germinal center and resting mem-
ory B cells are major reservoirs of long-term MHV-68 la-
tency in the spleen implies similarities and differences with
the proposed model for EBV latency, in which EBV gains
entry into the long-lived pool of resting memory B cells by
usurping the normal mechanisms of B cell activation (1, 4).
EBV encodes a viral gene, LMP-1, which directly mediates
CD40 signaling to induce polyclonal B cell activation and
differentiation (4, 32). This may allow EBV to enter mem-
ory B cells directly, by routes other than the germinal cen-
ter reaction (33). MHV-68, on the other hand, doesn’t
have an LMP-1 homologue, and seems to be dependent
upon CD4  T cells to induce B cell activation in vivo (34).
This dependence on CD4  T cell help is consistent with
the viral use of the germinal center reactions to establish la-
tency (our results and reference 14). Thus, is it possible that
 1- (EBV) and  2- (MHV-68) herpesviruses target many
of the same cellular pathways although they use different
strategies to achieve the same effects. KSHV, a  2-herpes-
virus, also establishes latency in B cells but the mechanism
is currently unknown.
Similar to what has been shown for EBV in lymphoid or-
gans (21, 35, 36), all the splenic B cell subsets analyzed har-
bor latent MHV-68. However, the initial EBV infection is
usually asymptomatic and current understanding of EBV la-
tency in vivo is mainly based on analysis of peripheral blood
and tonsils either during infectious mononucleosis or in
long-term asymptomatic individuals. At these time points,
when latency has already been established, latent EBV is
harbored preferentially in resting memory B cells in the pe-
ripheral blood (35, 37, 38), in naive, memory, and/or ger-
minal center B cells in the tonsil (21, 33), and in IgD  and
IgD  B cells in the spleen (36). An important advantage of
the mouse model is that the events that trigger the initial es-
tablishment of latency can be experimentally investigated.
A key finding of this study is that long-term latency in
the spleen is harbored not only in resting memory B cells,
but a comparable latent reservoir is also found in activated
germinal center B cells long after the initial infection. Con-
sistent with this, analysis of latency reservoirs in different
stages of cell cycle confirms that both resting and cycling
isotype-switched B cells harbor MHV-68. Not unexpect-
edly, these results differ from the previous cell cycle analysis
of latently EBV-infected peripheral blood B cells showing
that latency was harbored exclusively in resting cells (38).
The observation that long-term latency is harbored in
germinal center, memory, and naive B cells in the spleen
can be interpreted in two ways. One possibility is that
MHV-68  germinal center cells in the spleen reflect ongo-
ing viral reactivation, resulting in the reinfection of naive
B cells and reinitiation of the germinal center reaction in
the spleen. This has similarities with the observation that
EBV in the tonsil of asymptomatic carriers is harbored in B
cells with a naive (IgM  IgD ) phenotype, as well as mem-
ory and germinal center B cells (21). As the tonsil is a
known site of EBV reactivation, this has been interpreted
as infection of naive B cells by reactivating virus. Arguing
against this interpretation of the current data is the fact that
the spleen is not thought to be a site of reactivating MHV-
68. We and others have failed to show evidence for lytic
virus in immunocompetent mice (this report and refer-
ences 13, 14, and 17), although we cannot rule out the
possibility that there are a few lytically infected cells below
our limit of detection. An alternative explanation is that la-
tent virus in activated germinal center B cells reflects virus-
independent reactivation of latently infected memory B
cells driven by antigen or bystander activation. In this case,
the low frequency of latency among naive IgM  IgD  cells
may actually reflect selective latent infection of the subset
of IgD  IgM  B cells that are memory B cells (26, 27). As
the role of viral reactivation and reinfection in the mainte-1370 Establishment and Maintenance of  -Herpesvirus Latency
nance of  -herpesvirus latency has implications for thera-
peutic strategies, additional studies are necessary to resolve
these fundamental issues.
It is also possible that the frequency of latency in differ-
ent cell subsets 3 mo after infection is influenced by the
half life of the cells. However, the half life of a follicular B
cell in the spleen is 4.5 mo and is thought to be longer for
marginal zone B cells (39). Therefore, our analysis 3 mo after
infection should not be influenced by the life span of B cells.
This study represents the first analysis of MHV-68 gene
expression in long-term latently infected B cells. The de-
tection of transcripts putatively associated with latency
(M2, M9, and ORF 73), transcripts corresponding to genes
associated with viral reactivation from latency (ORF 50,
72, and M1), and lytic cycle transcripts (ORF 50 and K3),
suggests a complex mechanism of regulation of MHV-68
latent infection in distinct splenic B cell subsets (refer to
Table III for a brief description of the role of each gene). A
previous study of MHV-68 gene expression during latency
in B cell–deficient  MT mice (19) also detected expression
of ORFs M1, M2, M9, 72, and 74 in spleen cells, which
suggests an important role of those genes in splenic latency
independently of the host cell population. The absence of
M3 transcripts in B cells 3 mo after infection is consistent
with other studies. M3 could not be detected by in situ hy-
bridization of latently infected mouse spleens 21 d after in-
fection (40). Also, the expression of M3 transcripts detected
by RT-PCR was shown to be dramatically down-modu-
lated between 32 d and 10 mo after infection (41).
Transcription of the lytic genes ORF 50 and K3 in
memory B cells 3 mo after infection was unexpected as
these genes have been associated with reactivation from la-
tency and lytic cycle (19, 42–44) and we and others have
consistently failed to detect lytic virus in the spleen this late
after the infection of immunocompetent mice. In contrast,
the recent detection of EBV lytic gene expression in B cells
in the spleen suggests that the spleen, like the tonsil, is an
active site of EBV infection (36). Thus, it is possible that B
cells in the spleen are a site of MHV-68 reactivation below
the limits of detection and we are measuring gene tran-
scription by a low frequency of lytically infected cells. In
this sense, we consistently fail to detect transcription of M3
and M11. M3 encodes a chemokine scavenger and is
strongly expressed early in infection (40, 45–47). M11 is
required for in vivo reactivation from latency (48). There-
fore, our consistent failure to detect these transcripts corre-
lates with the absence of viral reactivation and reinfection
in the germinal center and memory B cells analyzed. An-
other possibility is that latently infected memory B cells are
continuously trying to reactivate and thus express early lytic
viral transcripts, but that viral reactivation is blocked before
the formation of infectious particles by the host immune
system. The idea that the virus is continually trying to reac-
tivate is also supported by the fact that in the absence of
both cellular and humoral immune surveillance (18, 49), or
in class II /  and IFN- R /  immunodeficient mice (10,
50), recrudescent lytic virus is readily detected. In addition,
continuous exposure to viral lytic antigens might explain
the sustained activation and cycling phenotype of CD4 
and CD8  T cells specific for MHV-68 lytic epitopes (51,
52) during long-term latent infection. Therefore, although
we cannot exclude the possibility that our assays to detect
lytic virus are not sensitive enough and/or we could be de-
tecting aberrant transcripts, it is also possible that lytic viral
genes are expressed but the virus is blocked from full reac-
tivation and production of lytic virus in the spleen.
Although the expression of a viral transcript does not
guarantee protein expression, the detection of multiple
transcripts is in apparent contrast to the virtual shutdown of
viral gene expression in peripheral blood memory B cells
harboring latent EBV (3, 38, 53). However, recent analysis
of EBV gene expression in tonsillar memory B cells and
spleen B cells has shown more promiscuous gene expres-
sion than in peripheral blood memory B cells (21, 36, 54,
55). These data suggest that  -herpesviruses gene expres-
sion in latently infected B cells varies with phenotype and
anatomical site.
In conclusion, the data provide a compelling argument
for  -herpesvirus utilization of the splenic B cell biology
during both the establishment and maintenance phases of
latent infection. Both viral latency and gene expression re-
sults support a complex interaction between the virus and
the B cell life cycle. It must be remembered, however, that
B cells are not the only reservoir of  2-herpesvirus latency.
We and others have shown that MHV-68 latency is estab-
lished in cells other than B cells, including macrophages
and dendritic cells (14, 56). Cell types other than B cells
have also been shown to be latently infected with KSHV
(57, 58). Thus, the different strategies for the establishment
and maintenance of  -herpesvirus latency in B cells are
only one aspect of a very complex strategy for survival.
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